Thursday, 20 January, 2022
{AU} Terry McCrann All eyes on interest rates in 2022 Outside of Covid the big talking point next year will be about whether interest rates go up, and if so how quickly and by how much? Ahead of its February meeting, the RBA will get the December quarter inflation numbers. They will be ‘interesting’. But it won’t get the next wages numbers until later in February ahead of its March meeting. That’s when we will […] Read More
Friday, 21 January, 2022
AFR: Why equities could fall sharply […] Read More
Wednesday, 19 January, 2022
From: Lorberg, Stuart <Stuart.Lorberg@cmegroup.com> Sent: 19 January 2022 12:11Subject: Useful chart & text – Liquidity is shifting to SOFR Good afternoon, Plse see below – a useful ref to the pace at which ED Futures are transitioning to SOFR at present + a reference once again to the recently enhanced ED/SOFR Futures ICS at finer pricing – 0.001 bp. All feedback welcome of course. Stu View […] Read More
Friday, 14 January, 2022
*AUSTRALIA CANCELS DJOKOVIC VISA: REPORTS Djokovic’s visa has been cancelled By Anthony Galloway Immigration Minister Alex Hawke has used his personal power to cancel Novak Djokovic’s visa, as his lawyers prepare to file an immediate injunction against the decision. The move has thrown the world tennis no.1’s quest for a 10th Australian Open into turmoil with the tournament to begin on Monday. If he doesn’t challenge the decision in the courts or is unsuccessful in […] Read More
Wednesday, 12 January, 2022
GUNDLACH…. *Gundlach focused heavily on signals that the U.S. economy could be weakening, saying that “I do think recessionary pressure is building” and comparing the state of the U.S. economy to the inflationary period in the 1970s under President Jimmy Carter. Consumer sentiment has weakened and “given up the ghost,” and looks to be at a recessionary level, Gundlach said. *Gundlach went through several data points suggesting that he was right last year to predict […] Read More
Tuesday, 11 January, 2022
By CHRISTOPHER LEONARD 12/28/2021 04:30 AM EST Christopher Leonard is a business reporter whose work has appeared in The Washington Post, The Wall Street Journal, Fortune and Bloomberg Businessweek. He is the author of The Meat Racket and Kochland, which won the J. Anthony Lukas Work-in-Progress Award. His new book, The Lords of Easy Money: How the Federal Reserve Broke the American Economy, is out January 11. Thomas Hoenig doesn’t look like a rebel. He […] Read More
Tuesday, 14 December, 2021
Street Views: BoA (Cabana, Axel): There will be 3 key points of focus at the Dec FOMC: (1) taper acceleration (2) SEP & dot plot, which will show a pull forward of hikes (3) balance sheet discussion & hints of QT. We expect the Fed to double the speed and reduce monthly TSY purchases by $20bn and MBS purchases by $10bn. The updated dot plot will likely reveal a pull forward in the dots, with […] Read More
Tuesday, 07 December, 2021
Terry McCrann – After February RBA meetings go ‘live’ again After the latest RBA board meeting it is clear Australia is moving closer to a rate rise, not just potentially in 2023 but possibly even relatively early next year. https://www.heraldsun.com.au/business/terry-mccrann/after-february-rba-meetings-go-live-again/news-story/7d38e9888fa403f550d9c60463cccd9e Reserve Bank Governor Philip Lowe and his fellow directors and RBA management have been on a journey over the last two months and which will reach its destination at the next […] Read More
Monday, 06 December, 2021
ANZ: If the Fed does accelerate the pace of its bond tapering, then we think the RBA could well decide to end its QE program altogether in February. This would be doubly so if the data over coming weeks means the RBA’s economic forecasts are upgraded in its February Statement on Monetary Policy. We don’t think the statement that will follow the RBA Board’s December meeting will allude to the possibility of QE ending […] Read More
Tuesday, 30 November, 2021
Existing vaccines will be less effective at tackling Omicron than earlier strains of Covid-19 and it may take months before pharmaceutical companies can manufacture new variant-specific jabs at scale, Moderna Chief Executive Stephane Bancel said in an interview with the Financial Times. The high number of Omicron mutations on the spike protein, which the virus uses to infect human cells, and the rapid spread of the variant in South Africa, suggested the current crop of […] Read More
